https://www.nasdaq.com/press-release/geovax-expands-gedeptinr-patent-portfolio-2025-05-07
GeoVax Expands Gedeptin(R) Patent Portfolio | Nasdaq
ATLANTA, GA- May 7, 2025- GeoVax Labs, Inc., a clinical-stage biotechnology company developing immunotherapies and vaccines against solid tumors and infectious...
patent portfolioexpandsnasdaq